Intratumoral adipocytes may contribute to breast cancer through inflammation, metastasis, and cancer stemness, but also associated with a favorable immune response that slows the cancer aggressiveness down, particularly in ER+/HER2- subtype. This evidence concerns the gene ERBB2 and cancer.